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WORLD-RENOWNED TRANSPLANT PIONEER ROBERT GOOD DIES
A pioneer in bone marrow transplant who was considered by many the
founder of modern cellular immunology has died at age 81. The cause of
death was esophageal cancer, his family has said.
Dr. Robert Alan Good was a pediatrician, microbiologist, and pathologist who
gained international recognition in a long and spectacular career that included
the first successful human bone marrow transplant in 1968.
The first marrow transplant involved a five-month-old boy with a profound
immune deficiency that had killed 11 male members of his extended family.
Dr. Good led a team at the University of Minnesota who corrected the fatal
condition with bone marrow extracted and infused from his 8-year-old sister.
The patient grew up to healthy adulthood and is reported to be alive today
and himself a father.
A native of Minnesota, Bob Good was six years of age when his father died of
cancer. From then on he wanted to become a physician and pursue research
that would cure disease.
He began teaching at the University of Minnesota in 1944, where he earned
his MD and PhD degrees. He first drew notice nationally in 1962 when he
reported his findings on the thymus gland to the annual meeting of the Feder-
ation of American Societies of Experimental Biology. He identified the thymus as
the primary source for the body’s defense mechanisms.
His discoveries helped establish that immunodeficiency diseases are not
rare, as once thought, but a frequent and very important basis of serious
disease in mankind. His studies led to the recognition and demonstration of the T-cell and B-cell arms of the immune
system and the development of useful methods of bone marrow transplantation.
In 1965 he reported evidence that tonsils, widely regarded as useless, actually had an important function in
developing the immune defense systems in mammals, including young humans, and he advised that they should be
removed only if involved in a serious health problem.
Dr. Good was recruited to Memorial Sloan-Kettering Cancer Center in 1973 as president and director of the
Sloan-Kettering Institute and director of research at Memorial Hospital. During
his tenure a new era of clinical investigations was initiated with many strong
programs at Memorial Hospital. Sloan-Kettering became one of the original
eight institutions recognized by the National Cancer Institute as a Compre-
hensive Cancer Center.
Since 1983, Dr. Good has been at All Children’s Hospital in St. Petersburg,
Fla., as physician-in-chief and, at the time of his death, Distinguished Research
Professor at the University of South Florida in Tampa.
Dr. Good received numerous awards and prizes during his 55 years in
medical research and science, including the Albert Lasker Clinical Research
Award for uniquely important contributions to the understanding of the
mechanisms of immunity, the discovery of the role of the thymus, and clinical
bone marrow transplantation. He was a founding member of the National
Institutes of Medicine. He was author, co-author, or editor of more than 2,000
papers and book chapters and trained hundreds of students in immunology.
Amember of ASBMT since its early days, Dr. Goodwas recently honored by the
Society when invited to present the annual E. Donnall Thomas Lecture at the
2000 Tandem BMTMeetings in Anaheim. At the conclusion of a dinner dedicated
to him and two eminent colleagues—Dr. Thomas and the late Dr. George
Santos—the line of bone marrow transplant colleagues, former students, in-
training fellows, and other well-wishers took an hour and a half to pass by.
Robert Alan Good, MD, PhD
1922–2003
Dr. Robert Good, right, is recognized on the
occasion of his presenting the E. Donnall
Thomas Lecture at the 2000 Tandem BMT
Meetings in Anaheim. Presenting the plaque
is ASBMT Past-President Dr. Keith Sullivan,
who chaired the scientific preogram for the
meeting.
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